Tandem Diabetes Care Inc. (TNDM)
Tandem Diabetes Care Statistics
Share Statistics
Tandem Diabetes Care has 66.47M shares outstanding. The number of shares has increased by 0.07% in one year.
| Shares Outstanding | 66.47M |
| Shares Change (YoY) | 0.07% |
| Shares Change (QoQ) | 0.32% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 65.92M |
| Failed to Deliver (FTD) Shares | 71 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 7.17M, so 10.92% of the outstanding shares have been sold short.
| Short Interest | 7.17M |
| Short % of Shares Out | 10.92% |
| Short % of Float | 11.01% |
| Short Ratio (days to cover) | 6.72 |
Valuation Ratios
The PE ratio is -24.55 and the forward PE ratio is -30.58. Tandem Diabetes Care's PEG ratio is 0.43.
| PE Ratio | -24.55 |
| Forward PE | -30.58 |
| PS Ratio | 2.51 |
| Forward PS | 0.9 |
| PB Ratio | 8.96 |
| P/FCF Ratio | 472.08 |
| PEG Ratio | 0.43 |
Enterprise Valuation
Tandem Diabetes Care Inc. has an Enterprise Value (EV) of 2.28B.
| EV / Earnings | -23.73 |
| EV / Sales | 2.42 |
| EV / EBITDA | -22.99 |
| EV / EBIT | -22.99 |
| EV / FCF | 456.26 |
Financial Position
The company has a current ratio of 2.93, with a Debt / Equity ratio of 1.8.
| Current Ratio | 2.93 |
| Quick Ratio | 2.33 |
| Debt / Equity | 1.8 |
| Total Debt / Capitalization | 64.29 |
| Cash Flow / Debt | 0.05 |
| Interest Coverage | -17.99 |
Financial Efficiency
Return on equity (ROE) is -0.36% and return on capital (ROIC) is -14.06%.
| Return on Equity (ROE) | -0.36% |
| Return on Assets (ROA) | -0.1% |
| Return on Capital (ROIC) | -14.06% |
| Revenue Per Employee | $354,793.58 |
| Profits Per Employee | $-36,235.85 |
| Employee Count | 2,650 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 3.01 |
Taxes
| Income Tax | 4.16M |
| Effective Tax Rate | -0.05 |
Stock Price Statistics
The stock price has increased by -44.11% in the last 52 weeks. The beta is 1.45, so Tandem Diabetes Care's price volatility has been higher than the market average.
| Beta | 1.45 |
| 52-Week Price Change | -44.11% |
| 50-Day Moving Average | 28.5 |
| 200-Day Moving Average | 36.02 |
| Relative Strength Index (RSI) | 33.9 |
| Average Volume (20 Days) | 1.52M |
Income Statement
In the last 12 months, Tandem Diabetes Care had revenue of 940.2M and earned -96.03M in profits. Earnings per share was -1.47.
| Revenue | 940.2M |
| Gross Profit | 489.57M |
| Operating Income | -99.13M |
| Net Income | -96.03M |
| EBITDA | -99.13M |
| EBIT | -99.13M |
| Earnings Per Share (EPS) | -1.47 |
Balance Sheet
The company has 69.23M in cash and 473.56M in debt, giving a net cash position of -404.33M.
| Cash & Cash Equivalents | 69.23M |
| Total Debt | 473.56M |
| Net Cash | -404.33M |
| Retained Earnings | -1.05B |
| Total Assets | 967.66M |
| Working Capital | 477.44M |
Cash Flow
In the last 12 months, operating cash flow was 24.23M and capital expenditures -19.23M, giving a free cash flow of 4.99M.
| Operating Cash Flow | 24.23M |
| Capital Expenditures | -19.23M |
| Free Cash Flow | 4.99M |
| FCF Per Share | 0.08 |
Margins
Gross margin is 52.07%, with operating and profit margins of -10.54% and -10.21%.
| Gross Margin | 52.07% |
| Operating Margin | -10.54% |
| Pretax Margin | -9.77% |
| Profit Margin | -10.21% |
| EBITDA Margin | -10.54% |
| EBIT Margin | -10.54% |
| FCF Margin | 0.53% |
Dividends & Yields
TNDM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -7.43% |
| FCF Yield | 0.38% |
Analyst Forecast
The average price target for TNDM is $53, which is 167.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $53 |
| Price Target Difference | 167.8% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
Stock Splits
The last stock split was on Oct 10, 2017. It was a backward split with a ratio of 1:10.
| Last Split Date | Oct 10, 2017 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 1.02 |
| Piotroski F-Score | 4 |